ATRC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 25, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 38 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 84%.
The 10-day RSI Indicator for ATRC moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 22 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on ATRC as a result. In 63 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +1.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in 215 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
ATRC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 157 of 222 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.841) is normal, around the industry mean (4.961). ATRC's P/E Ratio (269.545) is considerably higher than the industry average of (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.869) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for IRMD turned positive on September 21, 2026. Looking at past instances where IRMD's MACD turned positive, the stock continued to rise in 43 of 52 cases over the following month. The odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IRMD as a result. In 86 of 113 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
IRMD moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IRMD crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.
Following a +0.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in 192 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 215 of 270 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The 10-day RSI Indicator for IRMD moved out of overbought territory on October 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 24 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 68 cases where IRMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
IRMD broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.014) is normal, around the industry mean (2.874). P/E Ratio (48.420) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.180) is also within normal values, averaging (11.052). Dividend Yield (0.009) settles around the average of (0.009) among similar stocks. P/S Ratio (12.315) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
ATRC | IRMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 83 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 16 | |
SMR RATING 1..100 | 88 | 41 | |
PRICE GROWTH RATING 1..100 | 35 | 47 | |
P/E GROWTH RATING 1..100 | 7 | 39 | |
SEASONALITY SCORE 1..100 | 48 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IRMD's Valuation (87) in the Medical Specialties industry is in the same range as ATRC (94). This means that IRMD’s stock grew similarly to ATRC’s over the last 12 months.
IRMD's Profit vs Risk Rating (16) in the Medical Specialties industry is significantly better than the same rating for ATRC (100). This means that IRMD’s stock grew significantly faster than ATRC’s over the last 12 months.
IRMD's SMR Rating (41) in the Medical Specialties industry is somewhat better than the same rating for ATRC (88). This means that IRMD’s stock grew somewhat faster than ATRC’s over the last 12 months.
ATRC's Price Growth Rating (35) in the Medical Specialties industry is in the same range as IRMD (47). This means that ATRC’s stock grew similarly to IRMD’s over the last 12 months.
ATRC's P/E Growth Rating (7) in the Medical Specialties industry is in the same range as IRMD (39). This means that ATRC’s stock grew similarly to IRMD’s over the last 12 months.
| ATRC | IRMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 73% | 1 day ago 75% |
| Stochastic ODDS (%) | 1 day ago 74% | 1 day ago 62% |
| Momentum ODDS (%) | 1 day ago 79% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 84% | 2 days ago 83% |
| TrendWeek ODDS (%) | 1 day ago 73% | 1 day ago 64% |
| TrendMonth ODDS (%) | 1 day ago 72% | 1 day ago 81% |
| Advances ODDS (%) | 8 days ago 71% | 9 days ago 73% |
| Declines ODDS (%) | 4 days ago 83% | 1 day ago 60% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 60% |
| Aroon ODDS (%) | 1 day ago 71% | 1 day ago 80% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATRC’s FA Score shows that 1 FA rating(s) are green while IRMD’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATRC’s TA Score shows that 4 TA indicator(s) are bullish while IRMD’s TA Score has 6 bullish TA indicator(s).
ATRC (@Pharmaceuticals: Other) experienced а +2.63% price change this week, while IRMD (@Medical/Nursing Services) price change was -2.25% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
ATRC is expected to report earnings on Nov 03, 2026.
IRMD is expected to report earnings on Nov 02, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.
| Ticker / NAME | Correlation To IRMD | 1D Price Change % | ||
|---|---|---|---|---|
| IRMD | 100% | -0.19% | ||
| HBIO - IRMD | 45% Loosely correlated | -1.77% | ||
| PHG - IRMD | 42% Loosely correlated | +2.63% | ||
| TWST - IRMD | 41% Loosely correlated | -9.16% | ||
| ICUI - IRMD | 40% Loosely correlated | +4.66% | ||
| ATRC - IRMD | 38% Loosely correlated | +2.83% | ||
More | ||||